Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Nabpaclitaxel
DRUG
2 trials
Sponsors
Rutgers, The State University of New Jersey
, Gruppo Oncologico Italiano di Ricerca Clinica
Conditions
Endometrial Cancer
Ovarian Cancer
Recurrent Endometrial Cancer
Recurrent Ovarian Cancer
Small Cell Lung Cancer
Phase 1
Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer
Withdrawn
NCT02117817
Rutgers, The State University of New Jersey
Endometrial Cancer, Ovarian Cancer, Recurrent Endometrial Cancer +1
Start: 2015-02-28
End: 2015-02-25
Updated: 2022-07-28
Phase 2
Study of Nab-paclitaxel in Sensitive and Refractory Relapsed SCLC
NCT03219762
Gruppo Oncologico Italiano di Ricerca Clinica
Small Cell Lung Cancer
Start: 2017-02-07
End: 2019-01-31
Target: 65
Updated: 2017-07-26
Related Papers
Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)
British Journal of Cancer
2020-04-28
22 citations
Phase II study of NAB-paclitaxel in sensitive and refractory relapsed SCLC (NABSTER TRIAL)
Annals of Oncology
2018-10-01
2 citations